Recent Drug Developments and Law Update 2026 will be held Sunday, March 1st, 7:45 AM-1:30 PM hosted remotely via Zoom.
PLEASE NOTE: This 5 hour program is being offered as group continuing education attended individually on a personal computer or mobile device.
REGISTRATION WILL CLOSE FEBRUARY 27TH AT 5:00 PM
CANCELLATION POLICY: NO REFUNDS AFTER FEBRUARY 24TH
Presentations - Sunday March 1st, 2026
- "Vaccine Update 2026: Vaccinating in an uncertain world"
- “Pharmacotherapeutic Updates in the Treatment of Schizophrenia”
- “2026 Montana Pharmacy Law Update: New Requirements and Compliance Expectations”
- “Flushing out the Facts: What’s New in UTI Management”
- “Pharmacists’ Role in Heart Failure Care: Treatment Updates for HF with Preserved Ejection Fraction (HFpEF)”
Description
New drugs and new guideline recommendations continue to affect medical practice. This program will provide updates on the management of heart failure with preserved ejection fraction, treatment of urinary tract infections, and treatment for schizophrenia. Information on immunization updates and recommendations will be presented. In addition, an update from the Montana Board of Pharmacy will be provided.
Goal
The goal of this program is to discuss new drugs, compare them to other agents in the same pharmacological and/or therapeutic class, and discuss where these new agents fit into disease state management. In addition, an update of federal and Montana state pharmacy laws will be provided.
Objectives
At the conclusion of this program, the participant should be able to:
- Evaluate the newest immunization recommendations relevant to pharmacy practice, including newly approved vaccines, updated indications, dosing schedules, and age or risk-based eligibility
- Interpret current Montana laws and regulations regarding immunization authority, documentation, and reporting requirements for pharmacists, including scope of practice, prescriptive authority, and immunization registry participation
- Describe key elements leading to the removal of the clozapine REMS program
- Compare and contrast precautions and warnings between Cobenfy (xanomeline/trospium chloride) and other antipsychotic drugs
- Identify recent Administrative Rule changes impacting pharmacists in Montana
- Discuss Board of Pharmacy regulatory action and upcoming topics
- Discuss the role of emerging therapies in UTI treatment
- Evaluate the impact of updated UTI guidelines on clinical practice
- Discuss the underlying disease complexity of HFpEF and how it translates into treatment challenges
- Evaluate guideline-directed recommendations and recent clinical trial evidence to optimize pharmacist-driven care for patients with HFpEF
Activity Type: Knowledge-based
Target Audience: Pharmacists & Pharmacy Technicians (law portion only)
Accreditation Information
Skaggs School of Pharmacy at The University of Montana is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based activity. The Universal Activity Number (UAN) for the Recent Drug Development portion is 0035-0000-26-013-L01-P, and approved for 4 hours or 0.40 CEUs for Pharmacists. The Universal Activity Number for the Recent Law portion is 0035-0000-26-014-L03-P/T, and approved for 1 hour or 0.10 CEUs for Pharmacists and Pharmacy Technicians. In order to receive credits, participants must sign in to the presentation, view the entire presentation, and complete the program evaluation. CE credits will be uploaded to CPE Monitor within 60-days after the program.
Disclosure
Disclosure of Potential Conflicts of Interest: Skaggs School of Pharmacy at The University of Montana did not receive payment or services from a third party for any aspect of this activity and has no relationships (financial or other) with entities or activities that could be perceived to influence, or that give the appearance of potentially influencing any portion of this activity.
Program Coordinator
Sherrill Brown, DVM, Pharm. D., BCPS
Director, Drug Information Service
The University of Montana, College of Health
Speakers
Genine Pitts, Pharm.D. – Montana Board of Pharmacy
Andrew Eberling, PharmD – University of Montana Skaggs School of Pharmacy
Ian McGrane, PharmD – University of Montana Skaggs School of Pharmacy
Jenner Minto, PharmD – University of Montana Skaggs School of Pharmacy
Ken Chatriand, PharmD – University of Montana Skaggs School of Pharmacy
Contact us
E-mail: pharmacy.ce@umontana.edu